ID   KCC1G_HUMAN             Reviewed;         476 AA.
AC   Q96NX5; Q86UH5; Q9Y3J7;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2005, sequence version 3.
DT   12-OCT-2022, entry version 186.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase type 1G;
DE            EC=2.7.11.17;
DE   AltName: Full=CaM kinase I gamma;
DE            Short=CaM kinase IG;
DE            Short=CaM-KI gamma;
DE            Short=CaMKI gamma;
DE            Short=CaMKIG;
DE   AltName: Full=CaMK-like CREB kinase III;
DE            Short=CLICK III;
GN   Name=CAMK1G; Synonyms=CLICK3, VWS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ILE-329.
RX   PubMed=10645953;
RA   Schutte B.C., Bjork B.C., Coppage K.B., Malik M.I., Gregory S.G.,
RA   Scott D.J., Brentzell L.M., Watanabe Y., Dixon M.J., Murray J.C.;
RT   "A preliminary gene map for the Van der Woude syndrome critical region
RT   derived from 900 kb of genomic sequence at 1q32-q41.";
RL   Genome Res. 10:81-94(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=12637513; DOI=10.1074/jbc.m300578200;
RA   Takemoto-Kimura S., Terai H., Takamoto M., Ohmae S., Kikumura S., Segi E.,
RA   Arakawa Y., Furuyashiki T., Narumiya S., Bito H.;
RT   "Molecular cloning and characterization of CLICK-III/CaMKIgamma, a novel
RT   membrane-anchored neuronal Ca2+/calmodulin-dependent protein kinase
RT   (CaMK).";
RL   J. Biol. Chem. 278:18597-18605(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Rhodes S.;
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-259; ILE-329 AND THR-443.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase belonging to a
CC       proposed calcium-triggered signaling cascade. In vitro phosphorylates
CC       transcription factor CREB1 (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.17;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.17;
CC   -!- ACTIVITY REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin is thought to result in a conformational change and leads to
CC       activation through phosphorylation by CAMKK1 (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q96NX5; P21333-2: FLNA; NbExp=3; IntAct=EBI-3920838, EBI-9641086;
CC       Q96NX5; P28799: GRN; NbExp=3; IntAct=EBI-3920838, EBI-747754;
CC       Q96NX5; O60333-2: KIF1B; NbExp=3; IntAct=EBI-3920838, EBI-10975473;
CC       Q96NX5; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-3920838, EBI-10171774;
CC       Q96NX5; P31153: MAT2A; NbExp=3; IntAct=EBI-3920838, EBI-1050743;
CC       Q96NX5; O76024: WFS1; NbExp=3; IntAct=EBI-3920838, EBI-720609;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Golgi apparatus membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Cell membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96NX5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96NX5-2; Sequence=VSP_012138;
CC   -!- TISSUE SPECIFICITY: Mainly expressed in brain with small amounts in
CC       skeletal muscles, kidney, spleen and liver. Strongly expressed in
CC       forebrain neocortex, striatum and limbic system.
CC       {ECO:0000269|PubMed:12637513}.
CC   -!- DOMAIN: The autoinhibitory domain overlaps with the calmodulin binding
CC       region and interacts in the inactive folded state with the catalytic
CC       domain as a pseudosubstrate. {ECO:0000250}.
CC   -!- PTM: May be prenylated on Cys-473. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB41259.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF428261; AAL28100.1; -; mRNA.
DR   EMBL; AY212935; AAP29964.1; -; mRNA.
DR   EMBL; AL049688; CAB41259.1; ALT_INIT; mRNA.
DR   EMBL; AL023754; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032787; AAH32787.1; -; mRNA.
DR   CCDS; CCDS1486.1; -. [Q96NX5-1]
DR   RefSeq; NP_065172.1; NM_020439.2. [Q96NX5-1]
DR   RefSeq; XP_016857355.1; XM_017001866.1. [Q96NX5-1]
DR   PDB; 2JAM; X-ray; 1.70 A; A/B=18-316.
DR   PDBsum; 2JAM; -.
DR   AlphaFoldDB; Q96NX5; -.
DR   SMR; Q96NX5; -.
DR   BioGRID; 121424; 14.
DR   IntAct; Q96NX5; 12.
DR   STRING; 9606.ENSP00000009105; -.
DR   BindingDB; Q96NX5; -.
DR   ChEMBL; CHEMBL5258; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugBank; DB08009; SU-11652.
DR   DrugCentral; Q96NX5; -.
DR   iPTMnet; Q96NX5; -.
DR   PhosphoSitePlus; Q96NX5; -.
DR   BioMuta; CAMK1G; -.
DR   DMDM; 73620970; -.
DR   jPOST; Q96NX5; -.
DR   MassIVE; Q96NX5; -.
DR   PaxDb; Q96NX5; -.
DR   PeptideAtlas; Q96NX5; -.
DR   PRIDE; Q96NX5; -.
DR   ProteomicsDB; 77570; -. [Q96NX5-1]
DR   ProteomicsDB; 77571; -. [Q96NX5-2]
DR   Antibodypedia; 20698; 304 antibodies from 29 providers.
DR   DNASU; 57172; -.
DR   Ensembl; ENST00000009105.5; ENSP00000009105.1; ENSG00000008118.10. [Q96NX5-1]
DR   Ensembl; ENST00000361322.3; ENSP00000354861.2; ENSG00000008118.10. [Q96NX5-1]
DR   GeneID; 57172; -.
DR   KEGG; hsa:57172; -.
DR   MANE-Select; ENST00000361322.3; ENSP00000354861.2; NM_020439.3; NP_065172.1.
DR   UCSC; uc001hhd.4; human. [Q96NX5-1]
DR   CTD; 57172; -.
DR   DisGeNET; 57172; -.
DR   GeneCards; CAMK1G; -.
DR   HGNC; HGNC:14585; CAMK1G.
DR   HPA; ENSG00000008118; Group enriched (brain, kidney, ovary).
DR   MIM; 614994; gene.
DR   neXtProt; NX_Q96NX5; -.
DR   OpenTargets; ENSG00000008118; -.
DR   PharmGKB; PA26049; -.
DR   VEuPathDB; HostDB:ENSG00000008118; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   GeneTree; ENSGT00940000156872; -.
DR   HOGENOM; CLU_000288_63_0_1; -.
DR   InParanoid; Q96NX5; -.
DR   OMA; TGVCAIM; -.
DR   OrthoDB; 330091at2759; -.
DR   PhylomeDB; Q96NX5; -.
DR   TreeFam; TF314166; -.
DR   BRENDA; 2.7.11.17; 2681.
DR   PathwayCommons; Q96NX5; -.
DR   SignaLink; Q96NX5; -.
DR   SIGNOR; Q96NX5; -.
DR   BioGRID-ORCS; 57172; 10 hits in 1102 CRISPR screens.
DR   EvolutionaryTrace; Q96NX5; -.
DR   GenomeRNAi; 57172; -.
DR   Pharos; Q96NX5; Tchem.
DR   PRO; PR:Q96NX5; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q96NX5; protein.
DR   Bgee; ENSG00000008118; Expressed in frontal pole and 132 other tissues.
DR   ExpressionAtlas; Q96NX5; baseline and differential.
DR   Genevisible; Q96NX5; HS.
DR   GO; GO:0005954; C:calcium- and calmodulin-dependent protein kinase complex; IEA:Ensembl.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IBA:GO_Central.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IBA:GO_Central.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allosteric enzyme; Alternative splicing; ATP-binding;
KW   Calmodulin-binding; Cell membrane; Cytoplasm; Golgi apparatus; Kinase;
KW   Lipoprotein; Membrane; Nucleotide-binding; Prenylation; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..476
FT                   /note="Calcium/calmodulin-dependent protein kinase type 1G"
FT                   /id="PRO_0000086084"
FT   DOMAIN          23..277
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          277..317
FT                   /note="Autoinhibitory domain"
FT                   /evidence="ECO:0000250"
FT   REGION          297..318
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          325..352
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        338..352
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        143
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         29..37
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         52
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   VAR_SEQ         448..476
FT                   /note="NFKSEVMVPVKASGSSHCRAGQTGVCLIM -> YVFLAKDGAPAWV (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12637513"
FT                   /id="VSP_012138"
FT   VARIANT         259
FT                   /note="E -> Q (in dbSNP:rs35561962)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040600"
FT   VARIANT         329
FT                   /note="V -> I (in dbSNP:rs11119315)"
FT                   /evidence="ECO:0000269|PubMed:10645953,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_020530"
FT   VARIANT         443
FT                   /note="A -> T (in a breast infiltrating ductal carcinoma
FT                   sample; somatic mutation; dbSNP:rs1228276529)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040601"
FT   CONFLICT        427
FT                   /note="S -> N (in Ref. 1; AAL28100)"
FT                   /evidence="ECO:0000305"
FT   HELIX           19..22
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   STRAND          23..31
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   STRAND          33..42
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   TURN            43..45
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   STRAND          48..55
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   HELIX           64..74
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   STRAND          83..88
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   STRAND          90..97
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   HELIX           105..112
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   HELIX           117..136
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   HELIX           146..148
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   STRAND          150..155
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   STRAND          160..162
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   HELIX           177..180
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   TURN            188..190
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   STRAND          191..193
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   HELIX           198..214
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   TURN            218..221
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   HELIX           224..233
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   TURN            240..245
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   HELIX           248..258
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   TURN            262..264
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   HELIX           268..272
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   HELIX           275..278
FT                   /evidence="ECO:0007829|PDB:2JAM"
FT   HELIX           288..298
FT                   /evidence="ECO:0007829|PDB:2JAM"
SQ   SEQUENCE   476 AA;  53087 MW;  DD009D9CF2FE3CBE CRC64;
     MGRKEEDDCS SWKKQTTNIR KTFIFMEVLG SGAFSEVFLV KQRLTGKLFA LKCIKKSPAF
     RDSSLENEIA VLKKIKHENI VTLEDIYEST THYYLVMQLV SGGELFDRIL ERGVYTEKDA
     SLVIQQVLSA VKYLHENGIV HRDLKPENLL YLTPEENSKI MITDFGLSKM EQNGIMSTAC
     GTPGYVAPEV LAQKPYSKAV DCWSIGVITY ILLCGYPPFY EETESKLFEK IKEGYYEFES
     PFWDDISESA KDFICHLLEK DPNERYTCEK ALSHPWIDGN TALHRDIYPS VSLQIQKNFA
     KSKWRQAFNA AAVVHHMRKL HMNLHSPGVR PEVENRPPET QASETSRPSS PEITITEAPV
     LDHSVALPAL TQLPCQHGRR PTAPGGRSLN CLVNGSLHIS SSLVPMHQGS LAAGPCGCCS
     SCLNIGSKGK SSYCSEPTLL KKANKKQNFK SEVMVPVKAS GSSHCRAGQT GVCLIM
//
